By
Drug Target Review2023-09-22T10:00:27
Polycystic ovary syndrome (PCOS) is a widespread endocrine disorder affecting millions of women worldwide, profoundly impacting their hormonal equilibrium, fertility, and overall quality of life. This enigmatic condition, characterised by diverse symptoms and complex underlying causes, has long eluded effective treatment.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-10T09:00:00Z
2026-07-09T12:00:00Z
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2024-02-06T08:57:06
Sponsored by bit.bio
2024-01-26T13:22:42
Sponsored by bit.bio
2023-03-07T10:55:58
Sponsored by Agilent
2023-09-27T13:56:39
Sponsored by Euretos
Site powered by Webvision Cloud